Cengild Medical Berhad

KLSE:CENGILD Stock Report

Market Cap: RM258.2m

Cengild Medical Berhad Past Earnings Performance

Past criteria checks 1/6

Cengild Medical Berhad has been growing earnings at an average annual rate of 25.4%, while the Healthcare industry saw earnings growing at 24.3% annually. Revenues have been growing at an average rate of 13% per year. Cengild Medical Berhad's return on equity is 10.8%, and it has net margins of 17.8%.

Key information

25.4%

Earnings growth rate

-85.4%

EPS growth rate

Healthcare Industry Growth31.5%
Revenue growth rate13.0%
Return on equity10.8%
Net Margin17.8%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Cengild Medical Berhad (KLSE:CENGILD) Might Have The Makings Of A Multi-Bagger

Apr 05
Cengild Medical Berhad (KLSE:CENGILD) Might Have The Makings Of A Multi-Bagger

Investors Can Find Comfort In Cengild Medical Berhad's (KLSE:CENGILD) Earnings Quality

Sep 01
Investors Can Find Comfort In Cengild Medical Berhad's (KLSE:CENGILD) Earnings Quality

A Look At The Fair Value Of Cengild Medical Berhad (KLSE:CENGILD)

Aug 31
A Look At The Fair Value Of Cengild Medical Berhad (KLSE:CENGILD)

Revenue & Expenses Breakdown

How Cengild Medical Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KLSE:CENGILD Revenue, expenses and earnings (MYR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 246612180
31 Dec 236712180
30 Sep 237013170
30 Jun 237013160
31 Mar 237215150
31 Dec 227013140
30 Sep 226712140
30 Jun 22649140
31 Mar 22647150
31 Dec 21638140
30 Sep 21629130
30 Jun 216310120
30 Jun 20394100
30 Jun 1928190
30 Jun 1812-470

Quality Earnings: CENGILD has a high level of non-cash earnings.

Growing Profit Margin: CENGILD's current net profit margins (17.8%) are lower than last year (20.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CENGILD's earnings have grown significantly by 25.4% per year over the past 5 years.

Accelerating Growth: CENGILD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CENGILD had negative earnings growth (-20.6%) over the past year, making it difficult to compare to the Healthcare industry average (-3.6%).


Return on Equity

High ROE: CENGILD's Return on Equity (10.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.